VICAL INC (73) | Uncategorized (9)

Recent Contracts

Rights Agreement, dated as of May 3, 2022, by and among Brickell Biotech, Inc., Brickell Subsidiary, Inc., and Bodor Laboratories, Inc (Filed With SEC on May 3, 2022)
Description of the Registrants Securities Registered Pursuant to Section 12 of the Exchange Act (Filed With SEC on March 15, 2022)
Description of the Registrants Securities Registered Pursuant to Section 12 of the Exchange Act (Filed With SEC on March 9, 2021)
Letter Agreement, dated as of September 3, 2020, by and between Brickell Biotech, Inc. and Kaken Pharmaceutical Co., Ltd (Filed With SEC on October 13, 2020)
(Filed With SEC on September 1, 2020)
Right of First Negotiation Agreement, as amended, dated March 31, 2015, by and between Brickell Biotech, Inc. and Kaken Pharmaceutical Co., Ltd (Filed With SEC on September 3, 2019)
Brickell Biotech, Inc. Letter Agreement, dated July 10, 2018 by and between Brickell Biotech Inc. and Jose Breton (Filed With SEC on September 3, 2019)
Form of Support Agreement, dated June 2, 2019, by and between the Company and each of the parties named in each agreement therein (Filed With SEC on June 3, 2019)
Form of Lock-Up Agreement, dated June 2, 2019, by each of the parties named in each agreement therein (Filed With SEC on June 3, 2019)